Read More Pharma Industry News Novavax reports success for NVX-CoV2373 in pediatric group of phase 3 trial Novavax said that its Covid-19 vaccine NVX-CoV2373 achieved its primary effectiveness endpoint in the pediatric expansion of its… bySrinathFebruary 13, 2022
